Rigel Pharmaceuticals (RIGL) News Today $17.07 -1.38 (-7.48%) (As of 04:00 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Should You Buy the Dip on Rigel Pharmaceuticals (RIGL)?December 16 at 9:19 AM | wallstreetzen.comBrokerages Set Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) PT at $34.20December 14, 2024 | americanbankingnews.comCantor Fitzgerald Boosts Rigel Pharmaceuticals (NASDAQ:RIGL) Price Target to $25.00December 13, 2024 | americanbankingnews.comRecent 26% pullback isn't enough to hurt long-term Rigel Pharmaceuticals (NASDAQ:RIGL) shareholders, they're still up 50% over 1 yearDecember 12, 2024 | finance.yahoo.comRigel Pharmaceuticals price target raised to $25 from $15 at Cantor FitzgeraldDecember 11, 2024 | markets.businessinsider.comRigel Pharmaceuticals price target lowered to $20 from $27 at B. RileyDecember 11, 2024 | markets.businessinsider.comRigel Pharmaceuticals' (RIGL) Buy Rating Reaffirmed at HC WainwrightDecember 11, 2024 | americanbankingnews.comRigel Pharmaceuticals announces initial data from Phase 1b study of R289December 10, 2024 | markets.businessinsider.comRigel Pharmaceuticals (NASDAQ:RIGL) Given Buy Rating at HC WainwrightHC Wainwright reissued a "buy" rating and issued a $57.00 price objective on shares of Rigel Pharmaceuticals in a research note on Tuesday.December 10, 2024 | marketbeat.comRigel Highlights Initial Data from Ongoing Phase 1b Study Evaluating R289 in LR-MDS at the 66th ASH Annual Meeting and ExpositionDecember 9, 2024 | prnewswire.comRigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Receives Consensus Rating of "Hold" from AnalystsShares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL - Get Free Report) have been given an average rating of "Hold" by the five brokerages that are presently covering the firm, MarketBeat.com reports. Three investment analysts have rated the stock with a hold rating and two have assigned a buy ratinDecember 9, 2024 | marketbeat.comJacobs Levy Equity Management Inc. Sells 60,913 Shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)Jacobs Levy Equity Management Inc. reduced its stake in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL - Free Report) by 25.6% during the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 177,340 shares of the biotechnology company's stock after selling 60December 8, 2024 | marketbeat.comB. Riley Issues Positive Forecast for Rigel Pharmaceuticals (NASDAQ:RIGL) Stock PriceB. Riley upped their target price on Rigel Pharmaceuticals from $17.00 to $27.00 and gave the stock a "neutral" rating in a research note on Friday.December 6, 2024 | marketbeat.comRigel Pharmaceuticals price target raised to $27 from $17 at B. RileyDecember 6, 2024 | tipranks.comPDT Partners LLC Acquires New Stake in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)PDT Partners LLC bought a new stake in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL - Free Report) in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 19,914 shares of the biotechnology company's stock, valued at apDecember 4, 2024 | marketbeat.comRigel Pharmaceuticals, Inc.: Rigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk MDSDecember 2, 2024 | finanznachrichten.deRigel Pharmaceuticals announces R289 granted Fast Track designation by FDADecember 2, 2024 | tipranks.comRigel Announces R289 Granted Fast Track Designation by the FDA for Lower-Risk MDSDecember 2, 2024 | prnewswire.comRigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Sees Significant Decline in Short InterestRigel Pharmaceuticals, Inc. (NASDAQ:RIGL - Get Free Report) was the recipient of a significant decrease in short interest during the month of November. As of November 15th, there was short interest totalling 462,700 shares, a decrease of 30.0% from the October 31st total of 661,200 shares. Approximately 2.7% of the company's stock are sold short. Based on an average daily trading volume, of 198,500 shares, the short-interest ratio is currently 2.3 days.November 29, 2024 | marketbeat.comRigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Stock Holdings Lifted by Connor Clark & Lunn Investment Management Ltd.Connor Clark & Lunn Investment Management Ltd. lifted its holdings in shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL - Free Report) by 29.7% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 98,006 shares of thNovember 27, 2024 | marketbeat.comZacks.com featured highlights Rigel, Synchrony Financial, SkyWest, Allient and Rush Street InteractiveNovember 19, 2024 | finance.yahoo.comRigel (RIGL) Receives a Hold from Piper SandlerNovember 15, 2024 | markets.businessinsider.comLos Angeles Capital Management LLC Increases Stake in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)Los Angeles Capital Management LLC boosted its stake in shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL - Free Report) by 34.5% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 74,502 shares of the biotechnologNovember 15, 2024 | marketbeat.comRigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Given Average Rating of "Moderate Buy" by AnalystsRigel Pharmaceuticals, Inc. (NASDAQ:RIGL - Get Free Report) has earned an average recommendation of "Moderate Buy" from the four analysts that are currently covering the company, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a hold rating and two have assignedNovember 14, 2024 | marketbeat.comPiper Sandler Forecasts Strong Price Appreciation for Rigel Pharmaceuticals (NASDAQ:RIGL) StockPiper Sandler raised their target price on shares of Rigel Pharmaceuticals from $15.00 to $23.00 and gave the stock a "neutral" rating in a report on Thursday.November 14, 2024 | marketbeat.comRigel Pharmaceuticals price target raised to $49 from $40 at CitiNovember 13, 2024 | markets.businessinsider.comRigel to Present at the Jefferies London Healthcare ConferenceNovember 12, 2024 | prnewswire.comRigel’s Robust Financial Performance and Strategic Partnerships Drive Buy RatingNovember 10, 2024 | markets.businessinsider.comRigel Pharmaceuticals Reports Strong Q3 2024 ResultsNovember 9, 2024 | markets.businessinsider.comRigel stock rallies 36% after Q3 earnings beatNovember 9, 2024 | msn.comRigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Q3 2024 Earnings Call TranscriptNovember 9, 2024 | insidermonkey.comRigel Pharmaceuticals Inc (RIGL) Q3 2024 Earnings Call Highlights: Strong Sales Growth and ...November 8, 2024 | finance.yahoo.comQ3 2024 Rigel Pharmaceuticals Inc Earnings Call TranscriptNovember 8, 2024 | gurufocus.comRigel Pharmaceuticals, Inc. (RIGL) Q3 2024 Earnings Call TranscriptNovember 7, 2024 | seekingalpha.comRigel Reports Third Quarter 2024 Financial Results and Provides Business UpdateNovember 7, 2024 | prnewswire.comRigel Pharmaceuticals Inc (RIGL) Q3 2024 Earnings Report Preview: What To ExpectNovember 7, 2024 | finance.yahoo.comRigel Announces Six Poster Presentations at the 66th American Society of Hematology Annual Meeting and ExpositionNovember 5, 2024 | prnewswire.comRigel Pharmaceuticals (RIGL) to Release Quarterly Earnings on ThursdayRigel Pharmaceuticals (NASDAQ:RIGL) will be releasing earnings after the market closes on Thursday, November 7, Zacks reports.November 1, 2024 | marketbeat.comRigel Announces Conference Call and Webcast to Report Third Quarter 2024 Financial Results and Business UpdateOctober 31, 2024 | prnewswire.comAssenagon Asset Management S.A. Takes Position in Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL)Assenagon Asset Management S.A. bought a new position in shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL - Free Report) in the third quarter, according to the company in its most recent filing with the SEC. The firm bought 441,765 shares of the biotechnology company's stock, valued at approximatOctober 29, 2024 | marketbeat.comRigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Short Interest Up 54.9% in OctoberRigel Pharmaceuticals, Inc. (NASDAQ:RIGL - Get Free Report) was the recipient of a significant increase in short interest during the month of October. As of October 15th, there was short interest totalling 718,000 shares, an increase of 54.9% from the September 30th total of 463,500 shares. Based on an average daily volume of 135,900 shares, the short-interest ratio is presently 5.3 days. Currently, 4.2% of the shares of the company are sold short.October 27, 2024 | marketbeat.comRigel issues letter to doctors on fatal infection signal for GavretoOctober 25, 2024 | msn.comRigel Pharmaceuticals issues Dear Healthcare Provider letter for GavretoOctober 25, 2024 | markets.businessinsider.comHC Wainwright Reaffirms "Buy" Rating for Rigel Pharmaceuticals (NASDAQ:RIGL)HC Wainwright reissued a "buy" rating and set a $57.00 price target on shares of Rigel Pharmaceuticals in a research report on Friday.October 25, 2024 | marketbeat.comRigel Pharmaceuticals Issues Dear Healthcare Provider Letter for GAVRETO® (pralsetinib)October 24, 2024 | prnewswire.comRigel Pharmaceuticals (NASDAQ:RIGL) Raised to Strong-Buy at StockNews.comStockNews.com raised shares of Rigel Pharmaceuticals from a "buy" rating to a "strong-buy" rating in a research note on Friday.October 18, 2024 | marketbeat.comOptime Care Expands Partnership with Rigel Pharmaceuticals to Include Commercial Distribution for TAVALISSE®October 16, 2024 | globenewswire.comRigel Pharmaceuticals, Inc. (NASDAQ:RIGL) Shares Sold by Cubist Systematic Strategies LLCCubist Systematic Strategies LLC cut its stake in shares of Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL - Free Report) by 79.1% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 13,200 shares of tOctober 16, 2024 | marketbeat.comRigel Pharma Remains Bullish, Growth Fueled By FDA-Approved Drugs, Strategic PartnershipsOctober 10, 2024 | seekingalpha.comRigel Pharmaceuticals: Looking For More GrowthOctober 10, 2024 | seekingalpha.com Get Rigel Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RIGL and its competitors with MarketBeat's FREE daily newsletter. Email Address URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight. >> Register for the Workshop Now RIGL Media Mentions By Week RIGL Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RIGL News Sentiment▼0.400.56▲Average Medical News Sentiment RIGL News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RIGL Articles This Week▼43▲RIGL Articles Average Week Get Rigel Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RIGL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Myriad Genetics News Innoviva News OPKO Health News Ironwood Pharmaceuticals News Sangamo Therapeutics News Emergent BioSolutions News Codexis News XOMA News Vanda Pharmaceuticals News Verastem News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RIGL) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredAI Crypto Tool Could Send One Coin SOARING…The #1 AI Coin to Buy Rapid growth predicted for little-known AI crypto projectCrypto 101 Media | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rigel Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rigel Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free RIGL Stock Alerts